Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Shareholders of Rosseti Center and Volga Region approved dividends for 2023

6/14/24 MRKP

M.Video-Eldorado launched office equipment rentals

6/14/24 MVID

Trading in shares of MD Medical Group will begin on June 17

6/14/24 MDMG

5Post doubled the number of orders

6/14/24 X5

Rosbank wants to sell mortgage portfolio ahead of T-Bank deal

6/14/24 T

Rosbank wants to sell mortgage portfolio ahead of T-Bank deal

6/14/24 ROSB

Yandex will create a separate brand for unmanned cars and delivery robots

6/14/24 YDEX

Shareholders of IMCB approved dividends for 2023

6/14/24 GEMA

Magnit will build a new logistics complex in the Leningrad Region

6/13/24 MGNT

Yandex closed a deal to purchase the eLama service

6/13/24 YDEX